• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淋巴细胞减少预示食管鳞状细胞癌患者预后不良。

Lymphopenia predicts poor prognosis in patients with esophageal squamous cell carcinoma.

作者信息

Feng Ji-Feng, Liu Jin-Shi, Huang Ying

机构信息

From the Department of Thoracic Surgery (JFF, JSL) and Department of Operating Theatre (YH), Zhejiang Cancer Hospital, Hangzhou, China.

出版信息

Medicine (Baltimore). 2014 Dec;93(27):e257. doi: 10.1097/MD.0000000000000257.

DOI:10.1097/MD.0000000000000257
PMID:25501097
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4602783/
Abstract

Lymphopenia is a useful predictive factor in several cancers. The aim of this study was to determine the prognostic value of lymphopenia in patients with esophageal squamous cell carcinoma (ESCC).A retrospective analysis of 307 consecutive patients who had undergone esophagectomy for ESCC was conducted. In our study, a lymphocyte count (LC) of fewer than 1.0 Giga/L was defined as lymphopenia. Kaplan-Meier method was used to calculate the cancer-specific survival (CSS). Cox regression analyses were performed to evaluate the prognostic factors. Receiver operating characteristic (ROC) curve was also plotted to verify the accuracy of LC for CSS prediction.The mean LC was 1.55 ± 0.64 Giga/L (range 0.4-3.7 Giga/L). The incidence of lymphopenia (LC < 1.0 Giga/L) was 16.6% (51/307). Patients with lymphopenia (LC < 1.0 Giga/L) had a significantly shorter 5-year CSS (21.6% vs 43.8%, P = 0.004). On multivariate analysis, lymphopenia (LC < 1.0 Giga/L) was an independent prognostic factor in patients with ESCC (P = 0.013). Lymphopenia had a hazard ratio (HR) of 1.579 [95% confidence interval (CI): 1.100-2.265] for CSS. ROC curve demonstrated that lymphopenia (LC < 1.0 Giga/L) predicts survival with a sensitivity of 86.2% and a specificity of 27.2%. Lymphopenia (LC < 1.0 Giga/L) is still an independent predictive factor for long-term survival in patients with ESCC.

摘要

淋巴细胞减少在多种癌症中是一个有用的预测因素。本研究的目的是确定淋巴细胞减少在食管鳞状细胞癌(ESCC)患者中的预后价值。对307例连续接受ESCC食管切除术的患者进行了回顾性分析。在我们的研究中,淋巴细胞计数(LC)少于1.0千兆/升被定义为淋巴细胞减少。采用Kaplan-Meier法计算癌症特异性生存率(CSS)。进行Cox回归分析以评估预后因素。还绘制了受试者工作特征(ROC)曲线以验证LC对CSS预测的准确性。平均LC为1.55±0.64千兆/升(范围0.4 - 3.7千兆/升)。淋巴细胞减少(LC < 1.0千兆/升)的发生率为16.6%(51/307)。淋巴细胞减少(LC < 1.0千兆/升)的患者5年CSS显著缩短(21.6%对43.8%,P = 0.004)。多因素分析显示,淋巴细胞减少(LC < 1.0千兆/升)是ESCC患者的独立预后因素(P = 0.013)。淋巴细胞减少对CSS的风险比(HR)为1.579 [95%置信区间(CI):1.100 - 2.265]。ROC曲线表明,淋巴细胞减少(LC < 1.0千兆/升)预测生存的敏感性为86.2%,特异性为27.2%。淋巴细胞减少(LC < 1.0千兆/升)仍然是ESCC患者长期生存的独立预测因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/657b/4602783/94f23bf438a3/medi-93-e257-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/657b/4602783/ff7edcc21081/medi-93-e257-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/657b/4602783/8b5f3e756caa/medi-93-e257-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/657b/4602783/0f447bbaa14e/medi-93-e257-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/657b/4602783/94f23bf438a3/medi-93-e257-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/657b/4602783/ff7edcc21081/medi-93-e257-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/657b/4602783/8b5f3e756caa/medi-93-e257-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/657b/4602783/0f447bbaa14e/medi-93-e257-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/657b/4602783/94f23bf438a3/medi-93-e257-g006.jpg

相似文献

1
Lymphopenia predicts poor prognosis in patients with esophageal squamous cell carcinoma.淋巴细胞减少预示食管鳞状细胞癌患者预后不良。
Medicine (Baltimore). 2014 Dec;93(27):e257. doi: 10.1097/MD.0000000000000257.
2
Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma.中性粒细胞与淋巴细胞比值在可手术切除食管鳞状细胞癌中的预后作用
World J Gastroenterol. 2015 May 14;21(18):5591-7. doi: 10.3748/wjg.v21.i18.5591.
3
A novel inflammation-based prognostic score for patients with esophageal squamous cell carcinoma: the c-reactive protein/prognostic nutritional index ratio.一种基于炎症的食管癌鳞状细胞癌患者预后评分:C反应蛋白/预后营养指数比值
Oncotarget. 2016 Sep 20;7(38):62123-62132. doi: 10.18632/oncotarget.11389.
4
Pretreatment lymphopenia is an easily detectable predictive and prognostic marker in patients with metastatic esophagus squamous cell carcinoma receiving first-line chemotherapy.治疗前淋巴细胞减少是接受一线化疗的转移性食管鳞状细胞癌患者中一种易于检测的预测和预后标志物。
Cancer Med. 2016 May;5(5):778-86. doi: 10.1002/cam4.638. Epub 2016 Jan 26.
5
Systemic immune-inflammation index (SII) is a useful prognostic indicator for patients with squamous cell carcinoma of the esophagus.全身免疫炎症指数(SII)是食管鳞状细胞癌患者的一个有用的预后指标。
Medicine (Baltimore). 2017 Jan;96(4):e5886. doi: 10.1097/MD.0000000000005886.
6
Tumor length in elderly patients with esophageal squamous cell carcinoma: is it a prognostic factor?老年食管鳞癌患者的肿瘤长度:是预后因素吗?
Ups J Med Sci. 2013 Aug;118(3):145-52. doi: 10.3109/03009734.2013.792887. Epub 2013 Apr 26.
7
Diagnostic and prognostic value of serum L1-cell adhesion molecule in esophageal squamous cell carcinoma.血清 L1 细胞黏附分子在食管鳞状细胞癌中的诊断和预后价值。
Clin Res Hepatol Gastroenterol. 2018 Dec;42(6):597-603. doi: 10.1016/j.clinre.2018.08.010. Epub 2018 Sep 13.
8
Prognostic significance of Glasgow prognostic score in patients undergoing esophagectomy for esophageal squamous cell carcinoma.格拉斯哥预后评分在接受食管鳞癌切除术患者中的预后意义。
Saudi J Gastroenterol. 2014 Jan-Feb;20(1):48-53. doi: 10.4103/1319-3767.126319.
9
Prognostic significance of preoperative lymphocyte-monocyte ratio in patients with resectable esophageal squamous cell carcinoma.可切除食管鳞状细胞癌患者术前淋巴细胞与单核细胞比值的预后意义
Asian Pac J Cancer Prev. 2015;16(6):2245-50. doi: 10.7314/apjcp.2015.16.6.2245.
10
Preoperative squamous cell carcinoma antigen and albumin serum levels predict the survival of patients with stage T1-3N0M0 esophageal squamous cell carcinoma: a retrospective observational study.术前鳞状细胞癌抗原和血清白蛋白水平可预测T1-3N0M0期食管鳞状细胞癌患者的生存率:一项回顾性观察研究。
J Cardiothorac Surg. 2020 May 26;15(1):115. doi: 10.1186/s13019-020-01163-6.

引用本文的文献

1
Prehabilitation of Patients With Oesophageal Malignancy Undergoing Peri-Operative Treatment (Pre-EMPT): Outcomes From a Prospective Controlled Trial.接受围手术期治疗的食管癌患者的术前康复(Pre-EMPT):一项前瞻性对照试验的结果
J Surg Oncol. 2025 Jun;131(8):1508-1520. doi: 10.1002/jso.28079. Epub 2025 Jan 29.
2
Erythrocyte modified controlling nutritional status as a biomarker for predicting poor prognosis in post-surgery breast cancer patients.红细胞修饰控制营养状况作为预测乳腺癌术后患者预后不良的生物标志物。
Sci Rep. 2025 Jan 15;15(1):2071. doi: 10.1038/s41598-024-83729-1.
3
Enabling immune checkpoint blockade efficacy in T-lymphopenia by restoring CD8 T cell dynamics with IL-7 cytokine therapy.

本文引用的文献

1
Lymphopenia is an independent predictor of inferior outcome in papillary renal cell carcinoma.淋巴细胞减少是乳头状肾细胞癌预后不良的独立预测因素。
Urol Oncol. 2015 Sep;33(9):388.e19-25. doi: 10.1016/j.urolonc.2014.06.004. Epub 2014 Jul 11.
2
Surgery alone versus chemoradiotherapy followed by surgery for stage I and II esophageal cancer: final analysis of randomized controlled phase III trial FFCD 9901.手术与放化疗后手术治疗Ⅰ期和Ⅱ期食管癌的比较:FFCD 9901 期随机对照Ⅲ期试验的最终分析。
J Clin Oncol. 2014 Aug 10;32(23):2416-22. doi: 10.1200/JCO.2013.53.6532. Epub 2014 Jun 30.
3
Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities.
通过白细胞介素-7细胞因子疗法恢复CD8 T细胞动力学,使免疫检查点阻断在T淋巴细胞减少症中发挥疗效。
Front Immunol. 2024 Dec 16;15:1477171. doi: 10.3389/fimmu.2024.1477171. eCollection 2024.
4
Poor Prognostic Effects of Lymphocytopenia Induced by Preoperative Chemoradiotherapy in Rectal Cancer.术前放化疗引起的淋巴细胞减少对直肠癌预后不良。
Asian Pac J Cancer Prev. 2024 Nov 1;25(11):3799-3805. doi: 10.31557/APJCP.2024.25.11.3799.
5
Baseline absolute lymphocyte count as a prognostic indicator in advanced or metastatic breast cancer: a systematic review and meta-analysis.基线绝对淋巴细胞计数作为晚期或转移性乳腺癌的预后指标:一项系统评价和荟萃分析
Am J Transl Res. 2024 Sep 15;16(9):5049-5062. doi: 10.62347/ZXWY3004. eCollection 2024.
6
A Novel Risk Factor for Para-Aortic Lymph Node Recurrence After Definite Pelvic Radiotherapy in Stage IIIB Cervical Cancer.一种新的 IIIB 期宫颈癌根治性盆腔放疗后Para-Aortic 淋巴结复发的风险因素。
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221141541. doi: 10.1177/15330338221141541.
7
Is Lymphocyte C-Reactive Protein Ratio Useful for Predicting Survival in Patients with Non-Metastatic Soft Tissue Sarcoma?淋巴细胞与C反应蛋白比值对预测非转移性软组织肉瘤患者的生存率有用吗?
Cancers (Basel). 2022 Oct 24;14(21):5214. doi: 10.3390/cancers14215214.
8
Predictive Risk Factors Associated with Severe Radiation-Induced Mucositis in Nasopharyngeal or Oropharyngeal Cancer Patients: A Retrospective Study.鼻咽癌或口咽癌患者严重放射性口腔黏膜炎的预测风险因素:一项回顾性研究
Biomedicines. 2022 Oct 21;10(10):2661. doi: 10.3390/biomedicines10102661.
9
Clinico-Immunological Effects of a Single-Agent CDK4/6 Inhibitor in Advanced HR+/HER2- Breast Cancer Based on a Window of Opportunity Study.基于机会窗研究的单药CDK4/6抑制剂在晚期HR+/HER2-乳腺癌中的临床免疫效应
Curr Issues Mol Biol. 2022 Sep 15;44(9):4255-4267. doi: 10.3390/cimb44090292.
10
Significance of preoperative peripheral blood neutrophil-lymphocyte ratio in predicting postoperative survival in patients with multiple myeloma bone disease.术前外周血中性粒细胞与淋巴细胞比值对多发性骨髓瘤骨病患者术后生存的预测意义
World J Clin Cases. 2022 May 16;10(14):4380-4394. doi: 10.12998/wjcc.v10.i14.4380.
食管癌:流行病学、发病机制、分期检查及治疗方式综述
World J Gastrointest Oncol. 2014 May 15;6(5):112-20. doi: 10.4251/wjgo.v6.i5.112.
4
Investigation of neutrophil lymphocyte ratio and blood glucose regulation in patients with type 2 diabetes mellitus.2型糖尿病患者中性粒细胞与淋巴细胞比值及血糖调节的研究
J Int Med Res. 2014 Apr;42(2):581-8. doi: 10.1177/0300060513516944. Epub 2014 Feb 24.
5
Multimodality management of esophageal cancer.食管癌的多模态管理
Indian J Surg Oncol. 2013 Jun;4(2):96-104. doi: 10.1007/s13193-013-0216-0. Epub 2013 Jan 29.
6
Update on clinical impact, documentation, and management of complications associated with esophagectomy.食管切除术相关并发症的临床影响、记录和处理的最新进展。
Thorac Surg Clin. 2013 Nov;23(4):535-50. doi: 10.1016/j.thorsurg.2013.07.003.
7
Three-field or two-field resection for thoracic esophageal cancer: a meta-analysis.三野或二野切除术治疗胸段食管癌:一项荟萃分析。
Ann Thorac Surg. 2013 Dec;96(6):1933-41. doi: 10.1016/j.athoracsur.2013.06.050. Epub 2013 Sep 20.
8
Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor?术前血小板计数与食管鳞癌预后的关系:是一个预后因素吗?
Langenbecks Arch Surg. 2013 Dec;398(8):1115-22. doi: 10.1007/s00423-013-1111-4. Epub 2013 Sep 8.
9
Epidemiology of esophageal cancer in Japan and China.日本和中国食管癌的流行病学。
J Epidemiol. 2013;23(4):233-42. doi: 10.2188/jea.je20120162. Epub 2013 Apr 27.
10
Tumor length in elderly patients with esophageal squamous cell carcinoma: is it a prognostic factor?老年食管鳞癌患者的肿瘤长度:是预后因素吗?
Ups J Med Sci. 2013 Aug;118(3):145-52. doi: 10.3109/03009734.2013.792887. Epub 2013 Apr 26.